11 results
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Oral Hypoglycemics ... - PPAR gamma agonist ... AGENTS • GLP-1 agonists ... AmyChung #Oral #Hypoglycemics ... #pharmacology #
Insulin Dosing Basics - Initiating Insulin for T2DM and Converting Insulin Products 

Insulin dosing can be
Insulin Dosing Basics ... For type 2 diabetes ... for type 2 diabetes ... experience unexplained hypoglycemia ... #Prescribing #Pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... GLP-1 receptor agonist ... in Type 1 Diabetes ... monitors in Type 1 Diabetes ... #Medications #pharmacology
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... medications for insulin ... a low risk of hypoglycemia ... #Pharmacology #Dosing ... #Diabetes #DM2
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... cells, triggering insulin ... : Weight gain, Hypoglycemia ... Sulfonylureas #Pharmacology ... #Summary #DM2 #diabetes
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
the dose of an ACEi ... Continue ACEi or ... evidence-based pharmacologic ... #KDIGO #eGFR #Insulin ... #metformin #ACEi
Insulin Degludec (Tresiba) vs Insulin Glargine (Lantus, Basaglar, or Toujeo)

Insulin degludec (Tresiba) is an ultra-long acting
Insulin Degludec ... (Tresiba) vs Insulin ... incidence of severe hypoglycemia ... Glargine #Comparison #Pharmacology ... #DEVOTE #Diabetes
Emergent Hyperkalemia Treatment Algorithm
ECG changes, weakness, K+ >6.5 Or renal insufficiency with K >5.5 with cellular
+ beta-agonist ... reduction • Insulin ... Side effect: hypoglycemia ... <100 • Beta-agonist ... offending agent (ACE-I
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology ... glucose-dependent insulin ... #Pharmacology # ... Summary #DM2 #diabetes
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... • Increases insulin-mediated ... Does not cause hypoglycemia ... #Metformin #Pharmacology ... #Summary #DM2 #diabetes